BiotechTube
Home/MannKind Corp/James S. Shannon
JS

James S. Shannon

Chief Medical Officer

MannKind Corp

Therapeutic Areas

DiabetesPulmonary HypertensionHeart FailureChronic Kidney Disease

MannKind Corp Pipeline

DrugIndicationPhase
Afrezza®Type 1 Diabetes (Pediatrics - Newly Diagnosed)Phase 4
Tyvaso DPI®Pulmonary Arterial HypertensionApproved
V-Go®Diabetes (Insulin Delivery)Approved
FUROSCIX®Heart Failure / CKD (Pediatrics ≥43kg)Approved
FUROSCIX ReadyFlow™Heart Failure / CKDDevelopment
Technosphere® PlatformVarious (e.g., Glucagon)Discovery/Preclinical

Leadership Team at MannKind Corp

MC
Michael Castagna
Chief Executive Officer
CN
Chris Naftzger
Chief Financial Officer
SB
Steven B. Binder
President & Chief Operating Officer
DT
David Thomson
Chief Scientific Officer
View full MannKind Corp profile